Inverse Relationship Between Clock Gene Expression and Inflammatory Markers in Ulcerative Colitis Patients Undergoing Remission.
CRP
Circadian rhythms
Clinical remission
Clock gene expression
UC
Journal
Digestive diseases and sciences
ISSN: 1573-2568
Titre abrégé: Dig Dis Sci
Pays: United States
ID NLM: 7902782
Informations de publication
Date de publication:
06 2023
06 2023
Historique:
received:
27
10
2022
accepted:
24
01
2023
medline:
18
5
2023
pubmed:
7
2
2023
entrez:
6
2
2023
Statut:
ppublish
Résumé
Changes in the expression of clock genes have been reported in inflammatory bowel disease (IBD) patients. We aimed to investigate whether reduced inflammation restores clock gene expression to levels of healthy controls. This was a prospective study. Participants completed questionnaires providing data on demographics, sleeping habits, and disease activity. Anthropometric parameters, C-reactive protein (CRP), and fecal calprotectin (Fcal) levels were collected. Peripheral blood samples were analyzed for clock gene (CLOCK, BMAL1, CRY1, CRY2, PER1, PER2) expression. Patients with IBD were separated by diagnosis into ulcerative colitis (UC) and Crohn's disease (CD). Each diagnosis was further divided into active disease and disease under remission. Forty-nine patients with IBD and 19 healthy controls completed the study. BMAL1 and PER2 were significantly reduced in active patients with UC compared to patients with UC in remission. BMAL1, PER1, and PER2 were significantly reduced in patients with UC with CRP > 5 mg/dl. PER2, CRY1, and CRY2 were significantly reduced in patients with UC with Fcal > 250 mg/kg. Clock gene expression of patients with UC in remission was comparable to healthy controls. When all patients with IBD were analyzed, an overshoot in CRY1 expression was observed in patients in remission, patients with CRP < 5 mg/dl, and patients with Fcal < 250 mg/kg. CRP and Fcal are inversely related to clock gene levels in patients with UC. CRY1 may play a role in counteracting the anti-inflammatory processes when remission is induced in patients with IBD. ClinicalTrials.gov Identifier: NCT03662646.
Sections du résumé
BACKGROUND
Changes in the expression of clock genes have been reported in inflammatory bowel disease (IBD) patients.
AIMS
We aimed to investigate whether reduced inflammation restores clock gene expression to levels of healthy controls.
METHODS
This was a prospective study. Participants completed questionnaires providing data on demographics, sleeping habits, and disease activity. Anthropometric parameters, C-reactive protein (CRP), and fecal calprotectin (Fcal) levels were collected. Peripheral blood samples were analyzed for clock gene (CLOCK, BMAL1, CRY1, CRY2, PER1, PER2) expression. Patients with IBD were separated by diagnosis into ulcerative colitis (UC) and Crohn's disease (CD). Each diagnosis was further divided into active disease and disease under remission.
RESULTS
Forty-nine patients with IBD and 19 healthy controls completed the study. BMAL1 and PER2 were significantly reduced in active patients with UC compared to patients with UC in remission. BMAL1, PER1, and PER2 were significantly reduced in patients with UC with CRP > 5 mg/dl. PER2, CRY1, and CRY2 were significantly reduced in patients with UC with Fcal > 250 mg/kg. Clock gene expression of patients with UC in remission was comparable to healthy controls. When all patients with IBD were analyzed, an overshoot in CRY1 expression was observed in patients in remission, patients with CRP < 5 mg/dl, and patients with Fcal < 250 mg/kg.
CONCLUSION
CRP and Fcal are inversely related to clock gene levels in patients with UC. CRY1 may play a role in counteracting the anti-inflammatory processes when remission is induced in patients with IBD.
TRIAL REGISTRATION
ClinicalTrials.gov Identifier: NCT03662646.
Identifiants
pubmed: 36745299
doi: 10.1007/s10620-023-07847-y
pii: 10.1007/s10620-023-07847-y
doi:
Substances chimiques
ARNTL Transcription Factors
0
C-Reactive Protein
9007-41-4
Banques de données
ClinicalTrials.gov
['NCT03662646']
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2454-2462Informations de copyright
© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Références
Le Berre C, Ananthakrishnan AN, Danese S, Singh S, Peyrin-Biroulet L. Ulcerative Colitis and Crohn’s Disease Have Similar Burden and Goals for Treatment. Clin Gastroenterol Hepatol. 2020;18:14–23.
doi: 10.1016/j.cgh.2019.07.005
pubmed: 31301452
Agrawal M, Spencer EA, Colombel JF, Ungaro RC. Approach to the Management of Recently Diagnosed Inflammatory Bowel Disease Patients: A User’s Guide for Adult and Pediatric Gastroenterologists. Gastroenterology. 2021;161:47–65.
doi: 10.1053/j.gastro.2021.04.063
pubmed: 33940007
Turner D, Ricciuto A, Lewis A et al. STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD. Gastroenterology. 2021;160:1570–1583.
doi: 10.1053/j.gastro.2020.12.031
pubmed: 33359090
Ungaro R, Mehandru S, Allen PB, Peyrin-Biroulet L, Colombel JF. Ulcerative colitis. Lancet. 2017;389:1756–1770.
doi: 10.1016/S0140-6736(16)32126-2
pubmed: 27914657
Torres J, Mehandru S, Colombel JF, Peyrin-Biroulet L. Crohn’s disease. Lancet. 2017;389:1741–1755.
doi: 10.1016/S0140-6736(16)31711-1
pubmed: 27914655
Levine A, Sigall Boneh R, Wine E. Evolving role of diet in the pathogenesis and treatment of inflammatory bowel diseases. Gut. 2018.
Sobolewska-Wlodarczyk A, Wlodarczyk M, Szemraj J, Stec-Michalska K, Fichna J, Wisniewska-Jarosinska M. Circadian rhythm abnormalities - Association with the course of inflammatory bowel disease. Pharmacol Rep. 2016;68:847–851.
doi: 10.1016/j.pharep.2016.04.007
pubmed: 27166084
Hui L, Hua F, Diandong H, Hong Y. Effects of sleep and sleep deprivation on immunoglobulins and complement in humans. Brain Behav Immun. 2007;21:308–310.
doi: 10.1016/j.bbi.2006.09.005
pubmed: 17070668
Chowdhury EA, Richardson JD, Holman GD, Tsintzas K, Thompson D, Betts JA. The causal role of breakfast in energy balance and health: a randomized controlled trial in obese adults. Am J Clin Nutr. 2016;103:747–756.
doi: 10.3945/ajcn.115.122044
pubmed: 26864365
pmcid: 4763497
Parekh PJ, Oldfield Iv EC, Challapallisri V, Ware JC, Johnson DA. Sleep disorders and inflammatory disease activity: chicken or the egg? Am J Gastroenterol. 2015;110:484–488.
doi: 10.1038/ajg.2014.247
pubmed: 25155226
Froy O, Garaulet M. The Circadian Clock in White and Brown Adipose Tissue: Mechanistic, Endocrine, and Clinical Aspects. Endocr Rev. 2018;39:261–273.
doi: 10.1210/er.2017-00193
pubmed: 29490014
pmcid: 6456924
Allada R, Bass J. Circadian Mechanisms in Medicine. N Engl J Med. 2021;384:550–561.
doi: 10.1056/NEJMra1802337
pubmed: 33567194
pmcid: 8108270
Mosna K, Janega P, Sedlak J, Babal P. Complex changes of circadian proteins expression in inflammatory bowel disease. Bratisl Lek Listy. 2021;122:235–241.
pubmed: 33729814
Liu X, Yu R, Zhu L, Hou X, Zou K. Bidirectional Regulation of Circadian Disturbance and Inflammation in Inflammatory Bowel Disease. Inflamm Bowel Dis. 2017;23:1741–1751.
doi: 10.1097/MIB.0000000000001265
pubmed: 28902123
Palmieri O, Mazzoccoli G, Bossa F et al. Systematic analysis of circadian genes using genome-wide cDNA microarrays in the inflammatory bowel disease transcriptome. Chronobiol Int. 2015;32:903–916.
doi: 10.3109/07420528.2015.1050726
pubmed: 26172092
Weintraub Y, Cohen S, Chapnik N et al. Clock Gene Disruption Is an Initial Manifestation of Inflammatory Bowel Diseases. Clin Gastroenterol Hepatol. 2020;18(115–122):e111.
Levine A, Koletzko S, Turner D et al. ESPGHAN revised porto criteria for the diagnosis of inflammatory bowel disease in children and adolescents. J Pediatr Gastroenterol Nutr. 2014;58:795–806.
doi: 10.1097/MPG.0000000000000239
pubmed: 24231644
Elliott PR, Lennard-Jones JE, Hathway N. Simple index of Crohn’s disease activity. Lancet. 1980;1:876.
doi: 10.1016/S0140-6736(80)91372-0
pubmed: 6103229
Lewis JD, Chuai S, Nessel L, Lichtenstein GR, Aberra FN, Ellenberg JH. Use of the noninvasive components of the Mayo score to assess clinical response in ulcerative colitis. Inflamm Bowel Dis. 2008;14:1660–1666.
doi: 10.1002/ibd.20520
pubmed: 18623174
Turner D, Ruemmele FM, Orlanski-Meyer E et al. Management of Paediatric Ulcerative Colitis, Part 1: Ambulatory Care-An Evidence-based Guideline From European Crohn’s and Colitis Organization and European Society of Paediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr. 2018;67:257–291.
doi: 10.1097/MPG.0000000000002035
pubmed: 30044357
van Rheenen PF, Aloi M, Assa A et al. The Medical Management of Paediatric Crohn's Disease: an ECCO-ESPGHAN Guideline Update. J Crohns Colitis. 2020.
Horne JA, Ostberg O. A self-assessment questionnaire to determine morningness-eveningness in human circadian rhythms. Int J Chronobiol. 1976;4:97–110.
pubmed: 1027738
Bruni O, Ottaviano S, Guidetti V et al. The Sleep Disturbance Scale for Children (SDSC). Construction and validation of an instrument to evaluate sleep disturbances in childhood and adolescence. J Sleep Res. 1996;5:251–261.
LeBourgeois MK, Giannotti F, Cortesi F, Wolfson AR, Harsh J. The relationship between reported sleep quality and sleep hygiene in Italian and American adolescents. Pediatrics. 2005;115:257–265.
doi: 10.1542/peds.2004-0815H
pubmed: 15866860
Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28:193–213.
doi: 10.1016/0165-1781(89)90047-4
pubmed: 2748771
Sherman H, Frumin I, Gutman R et al. Long-term restricted feeding alters circadian expression and reduces the level of inflammatory and disease markers. J Cell Mol Med. 2011;15:2745–2759.
doi: 10.1111/j.1582-4934.2010.01160.x
pubmed: 20731750
pmcid: 4373423
Pham L, Baiocchi L, Kennedy L et al. The interplay between mast cells, pineal gland, and circadian rhythm: Links between histamine, melatonin, and inflammatory mediators. J Pineal Res. 2021;70:e12699.
doi: 10.1111/jpi.12699
pubmed: 33020940
Gachon F, Yeung J, Naef F. Cross-regulatory circuits linking inflammation, high-fat diet, and the circadian clock. Genes Dev. 2018;32:1359–1360.
doi: 10.1101/gad.320911.118
pubmed: 30385518
pmcid: 6217737
Ruiz Castro PA, Yepiskoposyan H, Gubian S et al. Systems biology approach highlights mechanistic differences between Crohn’s disease and ulcerative colitis. Sci Rep. 2021;11:11519.
doi: 10.1038/s41598-021-91124-3
pubmed: 34075172
pmcid: 8169754
Baxter M, Ray DW. Circadian rhythms in innate immunity and stress responses. Immunology. 2020;161:261–267.
doi: 10.1111/imm.13166
pubmed: 31820826
pmcid: 7692257
Lamia KA, Papp SJ, Yu RT et al. Cryptochromes mediate rhythmic repression of the glucocorticoid receptor. Nature. 2011;480:552–556.
doi: 10.1038/nature10700
pubmed: 22170608
pmcid: 3245818
Caratti G, Iqbal M, Hunter L et al. REVERBa couples the circadian clock to hepatic glucocorticoid action. J Clin Invest. 2018;128:4454–4471.
doi: 10.1172/JCI96138
pubmed: 30179226
pmcid: 6160001
Yang X, Geng J, Meng H. Glucocorticoid receptor modulates dendritic cell function in ulcerative colitis. Histol Histopathol. 2020;35:1379–1389.
pubmed: 32706033
Raine T, Bonovas S, Burisch J et al. ECCO Guidelines on Therapeutics in Ulcerative Colitis: Medical Treatment. J Crohns Colitis. 2022;16:2–17.
doi: 10.1093/ecco-jcc/jjab178
pubmed: 34635919